Efficacy and Safety of Urate Lowering Therapy (ULT) in CKD Patients With Gout

被引：0
|
作者：
Helget, Lindsay N. [1 ,2 ]
Davis-Karim, Anne [3 ]
O'Dell, James R. [1 ,2 ]
Mikuls, Ted R. [1 ,2 ]
Newcomb, Jeff A. [1 ]
Androsenko, Maria [4 ]
Brophy, Mary T. [4 ]
England, Bryant [1 ,2 ]
Ferguson, Ryan [4 ]
Pillinger, Michael [5 ,6 ]
Neogi, Tuhina [7 ]
Wu, Hongsheng [4 ]
Palevsky, Paul M. [8 ,9 ]
机构：
[1] VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA
[2] Univ Nebraska Med Ctr, Omaha, NE USA
[3] VA Cooperat Studies Program Clin Res Pharm Coordi, Albuquerque, NM USA
[4] VA Boston Cooperat Studies Program Coordinating C, Boston, MA USA
[5] VA New York Harbor Hlth Care Syst, New York, NY USA
[6] NYU Langone Hlth, New York, NY USA
[7] Boston Univ, Sch Med, Boston, MA USA
[8] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA
[9] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO895
引用
下载
收藏
页码：850 / 851
页数：2
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF A URATE LOWERING REGIMEN IN PRIMARY GOUT
    Bailen, Rebeca
    Gonzalez Senac, Nicolas M.
    Lopez, Monica M.
    Luisa Llena, M.
    Migoya, Marta
    Teresa Rodriguez, M.
    de Miguel, Eugenio
    Torres, Rosa J.
    Puig, Juan G.
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2014, 33 (4-6): : 174 - 180
  • [2] Urate lowering therapy for patients with gout on hemodialysis
    Alkilany, Reem
    Einstadter, Douglas
    Antonelli, Maria
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2023, 26 (03) : 585 - 585
  • [3] The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
    Robert L Jackson
    Barbara Hunt
    Patricia A MacDonald
    BMC Geriatrics, 12
  • [4] COMPARISON OF URATE-LOWERING EFFICACY AND SAFETY OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS
    Singh, Gajendera
    Kumar, Hemant
    Soni, Udit
    Tyagi, Shikhar
    Aggarwal, Kritika
    Verma, Kavita
    Kumar, Sumit
    HETEROCYCLIC LETTERS, 2016, 6 (01): : 133 - 147
  • [5] The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age
    Jackson, Robert L.
    Hunt, Barbara
    MacDonald, Patricia A.
    BMC GERIATRICS, 2012, 12
  • [6] Urate-lowering therapy for patients with gout on hemodialysis
    Alkilany, Reem
    Einstadter, Douglas
    Antonelli, Maria
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2022, 25 (07) : 769 - 774
  • [7] Women with gout: Efficacy and safety of urate-lowering with febuxostat and allopurinol
    Chohan, Saima
    Becker, Michael A.
    MacDonald, Patricia A.
    Chefo, Solomon
    Jackson, Robert L.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (02) : 256 - 261
  • [8] A SYSTEMATIC REVIEW OF GENETIC VARIANTS ASSOCIATED WITH THE SAFETY AND EFFICACY OF URATE-LOWERING THERAPY FOR PATIENTS WITH GOUT AND/OR HYPERURICEMIA.
    Wen, Y.
    Sayre, F.
    Nelson, J.
    Straka, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S21 - S22
  • [9] A SYSTEMATIC REVIEW OF GENETIC VARIANTS ASSOCIATED WITH THE SAFETY AND EFFICACY OF URATE-LOWERING THERAPY FOR PATIENTS WITH GOUT AND/OR HYPERURICEMIA.
    Wen, Y.
    Sayre, F.
    Nelson, J.
    Straka, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S54 - S54
  • [10] BUDGETARY IMPACT OF A NEW URATE-LOWERING THERAPY (ULT) FOR THE TREATMENT OF GOUT IN A US HEALTH PLAN FORMULARY
    Pandya, B. J.
    Quimbo, R. A.
    Mody, R.
    Srikanth, S.
    Dabbous, O.
    VALUE IN HEALTH, 2009, 12 (07) : A435 - A435
12345